FI104948B - Förfarande för framställning av salter av medetomidin för transdermalt administrering - Google Patents

Förfarande för framställning av salter av medetomidin för transdermalt administrering Download PDF

Info

Publication number
FI104948B
FI104948B FI935351A FI935351A FI104948B FI 104948 B FI104948 B FI 104948B FI 935351 A FI935351 A FI 935351A FI 935351 A FI935351 A FI 935351A FI 104948 B FI104948 B FI 104948B
Authority
FI
Finland
Prior art keywords
medetomidine
salts
skin
drug
base
Prior art date
Application number
FI935351A
Other languages
English (en)
Finnish (fi)
Other versions
FI935351A0 (fi
FI935351A (fi
Inventor
Harry Jalonen
Arto Karjalainen
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of FI935351A0 publication Critical patent/FI935351A0/fi
Publication of FI935351A publication Critical patent/FI935351A/fi
Application granted granted Critical
Publication of FI104948B publication Critical patent/FI104948B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Claims (2)

1. Förfarande för framställning av ett sait mellan medetomidin eller en optiskt aktiv enantiomer därav och en karboxylsyra med 5-16 kolatomer, 5 vilken karboxylsyra innehäller en alifatisk kolkedja med minst 5 kolatomer, kännetecknat därav, att man blandar medetomidinbas eller en optiskt aktiv enantiomer därav med sagt karboxylsyra, och isolerar det erhällna saltet.
2. Förfarande enligt patentkravet 1,kännetecknat därav, att man framställer dekanoat av medetomidin eller en optiskt aktiv enantiomer därav. 10 * 1 · «
FI935351A 1991-05-31 1993-11-30 Förfarande för framställning av salter av medetomidin för transdermalt administrering FI104948B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9111732 1991-05-31
GB919111732A GB9111732D0 (en) 1991-05-31 1991-05-31 The use of certain salts of medetomidine and its optically active enantiomers to regulate the rate of transdermal administration of the drugs
FI9200167 1992-05-27
PCT/FI1992/000167 WO1992021338A1 (en) 1991-05-31 1992-05-27 Medetomidine preparations for transdermal administration

Publications (3)

Publication Number Publication Date
FI935351A0 FI935351A0 (fi) 1993-11-30
FI935351A FI935351A (fi) 1993-11-30
FI104948B true FI104948B (sv) 2000-05-15

Family

ID=10695876

Family Applications (1)

Application Number Title Priority Date Filing Date
FI935351A FI104948B (sv) 1991-05-31 1993-11-30 Förfarande för framställning av salter av medetomidin för transdermalt administrering

Country Status (17)

Country Link
US (1) US5438067A (sv)
EP (1) EP0587819B1 (sv)
JP (2) JP3483881B2 (sv)
AT (1) ATE149090T1 (sv)
AU (1) AU1798192A (sv)
CA (1) CA2110161C (sv)
DE (1) DE69217658T2 (sv)
EE (1) EE03053B1 (sv)
FI (1) FI104948B (sv)
GB (2) GB9111732D0 (sv)
IE (1) IE67168B1 (sv)
LT (1) LT3130B (sv)
LV (1) LV10047B (sv)
NO (1) NO303818B1 (sv)
NZ (1) NZ242717A (sv)
WO (1) WO1992021338A1 (sv)
ZA (1) ZA923395B (sv)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5883115A (en) * 1992-11-09 1999-03-16 Pharmetrix Division Technical Chemicals & Products, Inc. Transdermal delivery of the eutomer of a chiral drug
GB2290964A (en) * 1994-07-08 1996-01-17 Arto Olavi Urtti Transdermal drug delivery system
GB9521680D0 (en) * 1995-10-23 1996-01-03 Orion Yhtymo Oy New use of imidazole derivatives
US5730721A (en) 1996-01-25 1998-03-24 Vesture Corporation Medical applicator and method
GB9614098D0 (en) 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan
IT1290255B1 (it) * 1997-02-05 1998-10-22 Wallcovering Pubblicita S R L Supporto sagomato aderente all'epidermide per la cessione di sostanze cosmetiche o farmacologiche e metodo per la sua fabbricazione
DE19936395C2 (de) 1999-08-03 2002-07-18 Antonia Buntz Kosmetikpflaster und Verfahren zum Anheben der weiblichen Brust mittels eines solchen Kosmetikpflasters und seine Verwendung
US6682757B1 (en) 2000-11-16 2004-01-27 Euro-Celtique, S.A. Titratable dosage transdermal delivery system
US7795263B2 (en) * 2008-07-08 2010-09-14 Wildlife Laboratories, Inc. Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals
AU2010248776B2 (en) * 2009-05-15 2013-06-06 Baudax Bio, Inc. Sublingual dexmedetomidine compositions and methods of use thereof
NZ703808A (en) * 2010-01-08 2016-01-29 Recro Pharma Inc Topical transdermal dexmedetomidine compositions and methods of use thereof
US20120202863A1 (en) * 2011-02-03 2012-08-09 Gerald Horn Compositions and methods for treatment of glaucoma
SG11201403094TA (en) 2011-12-11 2014-10-30 Recro Pharma Inc Intranasal dexmedetomidine compositions and methods of use thereof
KR101891186B1 (ko) * 2013-10-07 2018-08-24 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 조성물을 포함하는 통증을 관리하기 위한 방법 및 조성물
KR101831290B1 (ko) 2013-10-07 2018-02-22 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 조성물을 사용하여 주의력 결핍 과잉행동 장애, 불안 및 불면증을 치료하기 위한 방법 및 조성물
TWI704933B (zh) * 2013-10-07 2020-09-21 美商帝國製藥美國股份有限公司 右美托咪啶經皮輸送裝置及使用其之方法
FI3054934T3 (fi) * 2013-10-07 2024-07-19 Teikoku Pharma Usa Inc Menetelmät ja koostumukset vieroitusoireyhtymien hoitoon käyttäen ei-sedatiivisia transdermaalisia deksmedetomidiinikoostumuksia
CN105764496B (zh) * 2013-10-07 2020-09-25 帝国制药美国公司 用于经皮递送非镇静量的右旋美托咪啶的方法和组合物
US9974754B2 (en) 2013-12-18 2018-05-22 Maruishi Pharmaceutical Co., Ltd. Hydrous adhesive patch
CN111346072B (zh) * 2018-12-21 2022-05-27 宜昌人福药业有限责任公司 一种透皮给药的药物组合物及其制备方法
US20220211672A1 (en) 2019-05-01 2022-07-07 Clexio Biosciences Ltd. Methods of treating pruritus
US11185532B2 (en) 2019-05-01 2021-11-30 Clexio Biosciences Ltd. Methods of treating pruritus
TWI772807B (zh) 2019-05-27 2022-08-01 日商救急藥品工業股份有限公司 外用製劑

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
FI864570A0 (fi) * 1986-11-11 1986-11-11 Farmos Oy Terapeutiskt anvaendbar foerening.
GB2206880B (en) * 1987-07-16 1991-04-24 Farmos Oy Optical isomers of an imidazole derivative
GB2215206B (en) * 1988-02-29 1991-07-03 Farmos Oy 4-substituted imidazole derivatives useful in perioperative care
US5217718A (en) * 1989-08-18 1993-06-08 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
US5304569A (en) * 1989-11-13 1994-04-19 Orion-Yhtyma Oy Compositions and their use in lowering intraocular pressure

Also Published As

Publication number Publication date
JP2003327531A (ja) 2003-11-19
LV10047B (en) 1995-02-20
DE69217658T2 (de) 1997-07-03
ZA923395B (en) 1993-03-31
FI935351A0 (fi) 1993-11-30
EP0587819A1 (en) 1994-03-23
AU1798192A (en) 1993-01-08
CA2110161A1 (en) 1992-12-10
NO303818B1 (no) 1998-09-07
NO934323L (no) 1993-11-29
GB9211033D0 (en) 1992-07-08
IE67168B1 (en) 1996-03-06
JP3483881B2 (ja) 2004-01-06
EP0587819B1 (en) 1997-02-26
LT3130B (en) 1994-12-25
CA2110161C (en) 2004-08-03
US5438067A (en) 1995-08-01
GB9111732D0 (en) 1991-07-24
FI935351A (fi) 1993-11-30
ATE149090T1 (de) 1997-03-15
LTIP112A (en) 1994-07-15
NZ242717A (en) 1994-03-25
EE03053B1 (et) 1997-12-15
DE69217658D1 (de) 1997-04-03
GB2256367A (en) 1992-12-09
IE921937A1 (en) 1992-12-02
JPH06507888A (ja) 1994-09-08
GB2256367B (en) 1995-03-15
WO1992021338A1 (en) 1992-12-10
NO934323D0 (no) 1993-11-29
LV10047A (lv) 1994-05-10

Similar Documents

Publication Publication Date Title
FI104948B (sv) Förfarande för framställning av salter av medetomidin för transdermalt administrering
US5820875A (en) Device for administering drug transdermally with a controlled temporal change in skin flux
AU646606B2 (en) Transdermal administration of buprenorphine
HU221598B (hu) Glicerin alkalmazása bőrön keresztüli hatóanyag-bevitel szabályozására
US5464628A (en) Pharmaceutical compositions containing 4-substituted imidazoles to be administered transdermally
US20020192243A1 (en) Transdermal and topical administration of drugs for the treatment of Alzheimer's disease using basic enhancers
SK58095A3 (en) Transdermal therapeutic system for dosing of 17-beta-estradiol and process for its production
US6106856A (en) Transdermal delivery of calcium channel blockers, such as nifedipine
KR100624500B1 (ko) 레리세트론 전달용 경피치료시스템
US5750140A (en) Transdermal delivery of tiagabine
WO1989004179A1 (en) Pharmaceutical formulations for transdermal administration
HU206267B (en) Process for producing topical compositions comprising methane diphosphonic acid derivatives and their salts
US20020198215A1 (en) Terazosin transdermal device and methods
US20020192301A1 (en) Transdermal and topical administration of antihypertensive agents using basic enhancers
NZ245057A (en) Device for administering drug transdermally comprising a reservoir containing a drug and two solvents with a means for controlling the proportion of each solvent in the reservoir in order to control the drug flux

Legal Events

Date Code Title Description
MA Patent expired